Abstract
Pneumothorax had been reported in a few patients COVID-19. However, the significance and frequency of this association remains unclear. We report a 42-year-old man with COVID-19 disease who presented with sided hydropneumothorax. We managed the patient with intercostal tube drainage underwater seal, oxygen inhalation, injections remedesivir, dexamethasone, and ceftriaxone. The repeat computerised tomography scan of chest after 10 days revealed reduction in the left hydropneumothorax; no features suggestive of COVID-19 viral pneumoniawre evident.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
